Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501).
Masanori TerashimaYoshiaki IwasakiJunki MizusawaHiroshi KatayamaKenichi NakamuraHitoshi KataiTakaki YoshikawaYuichi ItoMasahide KajiYutaka KimuraMotohiro HiraoMakoto YamadaAkira KuritaMasakazu TakagiNarikazu BokuTakeshi SanoMitsuru Sasakonull nullPublished in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2019)
NAC for type 4 and large type 3 gastric cancer followed by D2 gastrectomy can be safely performed without increasing the morbidity or mortality.